On February 23, 2026, Labcorp (LH) disclosed one insider transaction. Executive Wilkinson Peter J sold 666 shares on February 19, 2026.
[Recent Insider Transactions]
Disclosure Date
Position
Name
Transaction Date
Buy/Sell
Quantity
Price per Share (USD)
Total Amount (USD)
2026-02-23
Executive
Wilkinson Peter J
2026-02-19
Sell
666
277.94
185,100
2026-02-13
Executive
Oyegunwa Akinbolade
2026-02-11
Sell
68
289.89
1,970
2026-02-13
Director
Schechter Adam H
2026-02-11
Sell
1,521
289.89
4,409,000
2026-02-13
Executive
Wang Julia Aijun
2026-02-11
Sell
245
289.89
7,100
2026-02-13
Executive
Summy Amy B.
2026-02-11
Sell
83
289.89
24,100
2026-02-13
Executive
GRAHAM ANITA Z
2026-02-11
Sell
109
289.89
3,160
2026-02-13
Executive
Kyle Kathryn W
2026-02-11
Sell
62
289.89
18,000
2026-02-13
Director
Schechter Adam H
2026-02-11
Sell
5,273
284.38
1,499,500
2026-02-13
Executive
van der Vaart Sandra D
2026-02-11
Sell
99
289.89
28,700
2026-02-13
Executive
Meltzer Jonathan C
2026-02-11
Sell
70
289.89
20,300
[Company Profile]
Labcorp Holdings Inc. is a Delaware corporation founded in 1971. The company is a leading global life sciences company with deep integration in guiding patient care. It offers comprehensive clinical laboratory and end-to-end drug development services through its LabCorp Diagnostics (LCD) and Covance Drug Development (CDD) divisions. Labcorp aims to integrate research and care delivery to achieve more precise and personalized healthcare, combining world-class diagnostic and drug development capabilities.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
US Stock Insider Trading | LeiboTech disclosed one insider trading transaction on February 23
On February 23, 2026, Labcorp (LH) disclosed one insider transaction. Executive Wilkinson Peter J sold 666 shares on February 19, 2026.
[Recent Insider Transactions]
[Company Profile]
Labcorp Holdings Inc. is a Delaware corporation founded in 1971. The company is a leading global life sciences company with deep integration in guiding patient care. It offers comprehensive clinical laboratory and end-to-end drug development services through its LabCorp Diagnostics (LCD) and Covance Drug Development (CDD) divisions. Labcorp aims to integrate research and care delivery to achieve more precise and personalized healthcare, combining world-class diagnostic and drug development capabilities.